Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2012-2024
- HEY3207231
- 87 Pages
- July 2019
- Medical Devices
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
The global Checkpoint Inhibitors for Treating Cancer market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
PD-1 inhibitors
PD-L1 inhibitors
CTLA-4 inhibitors
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Bristol-Myers Squibb(BMS)
Merck
Roche
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Melanoma treatment
Bladder cancer treatment
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 PD-1 inhibitors
1.2.1.2 PD-L1 inhibitors
1.2.1.3 CTLA-4 inhibitors
1.2.2 by Application
1.2.2.1 Melanoma treatment
1.2.2.2 Bladder cancer treatment
1.2.2.3 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 PD-1 inhibitors Market, 2013-2018
4.1.2 PD-L1 inhibitors Market, 2013-2018
4.1.3 CTLA-4 inhibitors Market, 2013-2018
4.2 Market Forecast
4.2.1 PD-1 inhibitors Market Forecast, 2019-2024
4.2.2 PD-L1 inhibitors Market Forecast, 2019-2024
4.2.3 CTLA-4 inhibitors Market Forecast, 2019-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Melanoma treatment Market, 2013-2018
5.1.2 Bladder cancer treatment Market, 2013-2018
5.1.3 Others Market, 2013-2018
5.2 Market Forecast
5.2.1 Melanoma treatment Market Forecast, 2019-2024
5.2.2 Bladder cancer treatment Market Forecast, 2019-2024
5.2.3 Others Market Forecast, 2019-2024
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Bristol-Myers Squibb(BMS)
8.2 Merck
8.3 Roche
9 Conclusion
Table Products Segment of Checkpoint Inhibitors for Treating Cancer
Table PD-1 inhibitors Overview
Table PD-L1 inhibitors Overview
Table CTLA-4 inhibitors Overview
Table Global Checkpoint Inhibitors for Treating Cancer Market by Type, 2011-2022 (USD Million)
Table Application Segment of Checkpoint Inhibitors for Treating Cancer
Table Melanoma treatment Overview
Table Bladder cancer treatment Overview
Table Others Overview
Table Global Checkpoint Inhibitors for Treating Cancer Market by Application, 2011-2022 (USD Million)
Table Global Checkpoint Inhibitors for Treating Cancer Market by Region, 2011-2022 (USD Million)
Table Cost of Checkpoint Inhibitors for Treating Cancer
Table Market Dynamics
Table Policy of Checkpoint Inhibitors for Treating Cancer
Table GDP of Major Countries
Table PD-1 inhibitors CAGR by Revenue and Volume, 2012-2018
Table PD-L1 inhibitors CAGR by Revenue and Volume, 2012-2018
Table CTLA-4 inhibitors CAGR by Revenue and Volume, 2012-2018
Table PD-1 inhibitors CAGR by Revenue and Volume, 2012-2024
Table PD-L1 inhibitors CAGR by Revenue and Volume, 2012-2024
Table CTLA-4 inhibitors CAGR by Revenue and Volume, 2012-2024
Table Melanoma treatment CAGR by Revenue and Volume, 2012-2018
Table Bladder cancer treatment CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global Checkpoint Inhibitors for Treating Cancer Market by Vendors, 2012-2018 (USD Million)
Table Global Checkpoint Inhibitors for Treating Cancer Market by Vendors, 2012-2018 (in Volume)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Vendors, 2012-2018 (USD Million)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Bristol-Myers Squibb(BMS) Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Profile List
Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
